Goodrx Holdings, Inc. Stock Price, News & Analysis

GoodRx (NASDAQ: GDRX) has announced an agreement to acquire vitaCare Prescription Services from TherapeuticsMD for $150 million, plus up to $7 million contingent on performance through 2023. The acquisition aims to enhance patient access and adherence to brand medications by addressing affordability and insurance communication barriers. GoodRx expects this transaction to contribute under 1% to overall revenue and reduce adjusted EBITDA margin by about 2% in 2022, while anticipates future growth in revenue and profitability.

GoodRx Holdings has released its fourth quarter and full year 2021 financial results, highlighting its role as a leading digital healthcare platform. The company has saved consumers over $35 billion since its inception in 2011. A conference call to discuss these results is scheduled for today at 2:00 p.m. PT. Investors can access the live call and its archive on the GoodRx investor relations website.

GoodRx continues to grow as one of the most downloaded medical apps.

GoodRx Holdings has announced a new share repurchase program authorized to buy back up to $250 million of its Class A Common Stock. The program aims to enhance shareholder value and reflects the company's confidence in its future growth. Repurchases will be executed based on market conditions, using existing cash and cash equivalents, with reports indicating $941.1 million in cash available as of December 31, 2021. The program is effective immediately and may be modified or terminated by the Board at their discretion before February 23, 2024.

GoodRx Holdings Inc. (NASDAQ: GDRX) announced its participation in key investor conferences in March. Executives will present at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL, on March 8 at 7:25 a.m. PT; at the Cowen 42nd Annual Health Care Conference virtually on March 9 at 8:10 a.m. PT; and at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference in Palm Beach, FL, on March 15 at 6:35 a.m. PT. Live webcasts and archived recordings will be accessible via their Investor Relations website.

GoodRx Holdings Inc. (NASDAQ: GDRX) will release its fourth quarter and full year 2021 financial results after U.S. markets close on February 28, 2022. A conference call will occur at 2:00 p.m. PT to discuss the results and future outlook. The financial results will be available on their investor relations website. GoodRx, a leading digital healthcare platform, has helped consumers save over $35 billion since 2011, establishing itself as a crucial resource for affordable healthcare.

GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live webcast of the presentation will be accessible via the Company’s Investor Relations website, and an archived recording will be available for at least 30 days post-conference. Since its inception in 2011, GoodRx has helped Americans save over $35 billion, making healthcare more affordable and convenient.

GoodRx Holdings Inc. (NASDAQ: GDRX) has announced participation in two upcoming investor conferences. The first is the Credit Suisse 25th Annual Technology Conference on December 1, 2021, at 1:20 p.m. PT in Scottsdale, AZ. The second is the Barclays Global Technology, Media and Telecommunications Conference on December 7, 2021, at 11:25 a.m. PT, held virtually. Live webcasts and presentation materials will be accessible on the Company's Investor Relations website, with archived recordings available for 30 days post-conference.

GoodRx has released its State of Telehealth report, highlighting significant changes in telehealth usage due to the COVID-19 pandemic. Over 1,600 providers and patients were surveyed, revealing that 40% of consumers feel they interact more with providers via telehealth. Additionally, 70% of providers noted improved continuity of care. Post-pandemic, 60% of consumers plan to adopt a hybrid model of care. While 45% of providers reported higher no-show rates for telehealth appointments, overall satisfaction remains high, with GoodRx's telehealth service achieving a 92% satisfaction rate and saving consumers an estimated $243 million in medical costs.

GoodRx Holdings, Inc. (GDRX) announced its third quarter 2021 financial results, highlighting its role as a digital healthcare resource that has saved consumers $35 billion since inception in 2011. The company hosted a conference call on November 10, 2021, at 2:00 PM PT to discuss these results and its business outlook. GoodRx is recognized as one of the most downloaded medical apps, emphasizing its significant impact on healthcare affordability and access in the U.S.